Abstract:This paper studies novel techniques for synthesizing 3‐Amino‐5,6‐Dimethyl‐l,2,4‐triazine, and new l,2,4‐triazine derivatives under free solvent conditions. All the target compounds were synthesized in accepTable quantities. Furthermore, NCI selected some of the synthesized compounds to test for potential in vitro anticancer activity against a panel of sixty human cancer cell lines covering nine tumor panels. Two effective one‐pot synthesis procedures were proposed for the synthesis of 3‐amino‐5,6‐dimethyl‐l,2,4‐triazine under free solvent conditions; these methods included fusing the monohydrazide of biacetyl with either methyl carbamimidothioate (Method B) or cyanamide (Method C). Simple reaction conditions, an easy work‐up process, and facile separation characterize the ecologically friendly fusion process used in techniques B and C. The results from methods B and C indicated the existence of amino‐imino prototropic tautomerism. The triazine in method C had a different melting point and had unusual mass spectral behavior, suggesting that it was in the imino‐tautomer form, as opposed to the amino‐tautomer form discovered in procedure B. The strong electron‐withdrawing activity of the triazine ring appears to deactivate the 3‐amino group, which in turn triggers the production of additional triazine derivatives (3–12), with yields ranging from 54% to 82%. To characterize the structure of the newly synthesized compounds, 1H, 13C‐NMR, and mass spectrometry were employed. The compounds that were created underwent testing at the National Cancer Institute. According to the screening results, conjugates 9 and 10 were successful against most of the cancer cell line subpanels. With the use of DFT, we conducted theoretical studies on compounds 9 and 10. Topological studies, including ELF, LOL, and RDG, were used to identify the main binding sites and weak interactions of the target derivatives. The synthesized compounds that have promising properties are subjected to a pharmacological examination using Swiss‐ADME. Cox‐1 (PDB ID: 3KK6) is the target of molecular docking experiments that aim to identify the anticancer active site of the derivatives of interest.

s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation

Recent Advances in the Biological Activity of s-Triazine Core Compounds

1,3,5-Triazine: Recent Development in Synthesis of its Analogs and Biological Profile

Antitumor Activity of s-Triazine Derivatives: A Systematic Review

Triazole: A New Perspective in Medicinal Chemistry and Material Science

Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery

Biological importance and synthesis of 1,2,3-triazole derivatives: a review

An insight on medicinal attributes of 1,2,4-triazoles

Synthetic Methodology, SAR and Pharmacology of Commercialized Preparations Employing 1, 2, 4‐Triazole Analogues

Significance of Triazole in Medicinal Chemistry: Advancement in Drug Design, Reward and Biological Activity

Recent Advancements and Developments in the Biological Importance of 1,3,5‐Triazines

Halo‐1,2,3‐triazole: valuable compounds to access biologically relevant molecules

Exploring Triazole-Connected Steroid-Pyrimidine Hybrids: Synthesis, Spectroscopic Characterization, and Biological Assessment

Cysteine‐Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5‐Substituted 1,2,3‐Triazines

Triazolopyrimidine Derivatives: an Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects

Synthesis and Reactions of 3‐Amino‐5,6‐Dimethyl‐l,2,4‐Triazine: DFT Studies, ADME Assay, and Molecular Docking on the new l,2,4‐Triazine Derivatives as Anticancer Agents.

Chemistry and Biological Activities of 1,2,4-Triazolethiones—Antiviral and Anti-Infective Drugs

Emerging Aspects of Triazole in Organic Synthesis: Exploring its Potential as a Gelator

Recent Progress on Synthesis of Functionalized 1,5-Disubstituted Triazoles

Exploring The Antimicrobial Potential of Novel 1,2,4-Triazole Conjugates with Pyrazole: Synthesis, Biological Activity and In Silico Docking

1,2,3-Triazole Hybrids Containing Isatins and Phenolic Moieties: Regioselective Synthesis and Molecular Docking Studies